Medicsight to restate 2001, 2002 results

Image analysis software maker Medicsight reported that it is reauditing and restating its 2001 and 2002 financial statements, after reviewing a transaction that took place in November 2001.

As a result of the decision to refile, the company won't be able to file its quarterly report for the third quarter of 2003 with the U.S. Securities and Exchange Commission, London-based Medicsight said.

In other financial news, the company has filed an information statement proposing an increase in its authorized share capital from 25 million shares to 40 million shares. The increase in share capital has been approved by shareholders and will take effect as soon as the firm receives regulatory approval. Currently, more than 24 million shares are in issue, Medicsight said.

By staff writers
January 20, 2004

Related Reading

Medicsight gets CE Mark, financing, October 8, 2003

Lifesyne CT screening center opens in London, May 14, 2003

Medicsight continues U.K. plans, eyes U.S. imaging center market, April 16, 2003

Copyright © 2004

Page 1 of 156
Next Page